News

Mounjaro went head-to-head against Wegovy with one clear winner as the new 'weight loss jab' to be rolled out across UK
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
GEN - Genetic Engineering and Biotechnology News29m
Lilly to Acquire Verve Therapeutics for Up to $1.3B
Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion in a deal designed to bolster the buyer’s cardiovascular treatment pipeline with Verve’s gene editing therapies, led by ...
Mark Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs
(Reuters) -Telehealth firm 9amHealth has partnered with billionaire entrepreneur Mark Cuban's Cost Plus Drug Company to offer ...
Eli Lilly Buys Verve Therapeutics: Aims To Permanently Lower Your Cholesterol
Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...